| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.01 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |